Ovarian Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Debra Richardson, including the following topics: Targeting folate receptor alpha in ovarian cancer; activity, tolerability and ongoing investigation of the antibody-drug conjugate (ADC) mirvetuximab soravtansine (0:00) Other ADCs under investigation for patients with ovarian cancer (20:05) Mechanism of action and activity of upifitamab rilsodotin (UpRi) for patients with pretreated ovarian cancer (23:27) Emerging strategies for patients with platinum-resistant ovarian cancer (29:53) Rationale for the discontinuation of clinical development of UpRi (33:17) CME information and select publications